Peptides & Research Chemicals
SS-31 (Elamipretide)
Street names: Elamipretide, SS-31 peptide
Overdose? Act now. Call emergency services — say "unresponsive, not breathing". Give naloxone for opioid-like signs. Hotlines
⚡What it does
- Mitochondria-targeted peptide — cellular-energy claims
- In trials for mitochondrial diseases and heart/kidney conditions
⚠Key risks
- Not approved — trial data is early
- 'Research chemical' supply has no relation to trial-grade material
- Unknown long-term effects
✚Overdose signs
- Unknown in humans
- Injection-site infection
📋Quick facts
Also known asElamipretide, SS-31 peptide
CategoryPeptides & Research Chemicals
Schedule / classInvestigational drug — clinical trials ongoing; grey supply unscheduled
AppearanceLyophilized vials
Street price~$40–$90 per vial grey-market
Legal statusInvestigational; grey-market supply unregulated
Last updated2026-09-16
Sources: PubMed, FDA
Category comparison — Peptides & Research Chemicals
| Substance | Class | Top risks | Street price |
|---|---|---|---|
| SS-31 (Elamipretide) | Investigational drug — clinical trials ongoing; grey supply unscheduled | Not approved — trial data is early; 'Research chemical' supply has no relation to trial-grade material | ~$40–$90 per vial grey-market |
| MOTS-C | 'Research chemical' — no human approval | No human trials — all effects anecdotal; Exercise-mimetic claims are ahead of any evidence | ~$30–$70 per vial grey-market |
| Epitalon (Epithalon) | 'Research chemical' — no human approval | Human evidence is thin and old — anti-aging claims far outrun data; Cancer-theoretical concerns with telomerase-active compounds | ~$20–$50 per vial grey-market |
Street prices are regional estimates. Potency and cuts vary constantly.
RxBrand names on the grey market
These brands are sold as this compound. Same molecule, different label and supply chain — quality varies enormously between them.
SS-31
?Frequently asked questions
What does SS-31 (Elamipretide) look like?
Lyophilized vials
What are the signs of a SS-31 (Elamipretide) overdose?
Unknown in humans; Injection-site infection Call emergency services immediately.
How addictive is it?
Not approved — trial data is early Dependence can develop with regular use.